Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Parkinson's disease is a complex neurodegenerative disorder for which both rare and
common genetic variants contribute to disease risk, onset, and progression. Mutations in more …

Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

Parkinson’s disease is a genetically complex disorder. Multiple genes have been shown to
contribute to the risk of Parkinson’s disease, and currently 90 independent risk variants have …

Genetics has proven to be a powerful approach in neurodegenerative diseases research,
resulting in the identification of numerous causal and risk variants. Previously, we introduced …

Objective Parkinson's disease (PD) is a complex neurodegenerative disorder. Men are on
average ~ 1.5 times more likely to develop PD compared to women with European ancestry. …

Methods We investigated the frequencies and mutations in neurodegenerative disease
genes in 121 consecutive FTD subjects using an unbiased, combined sequencing approach, …

With recent findings connecting the Epstein-Barr virus to an increased risk of multiple sclerosis
and growing concerns regarding the neurological impact of the coronavirus pandemic, …

Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

Importance Recent genome-wide association studies (GWAS) and pathway analyses supported
long-standing observations of an association between immune-mediated diseases and …